Here is the link to the study. Click through on that page for the full text in PDF format.
Nardelli, et al. “Crying wolf in time of Corona: the strange case of ivermectin and hydroxychloroquine. Is the fear of failure withholding potential life-saving treatment from clinical use?”
Online publish date: 11 March 2021
The study analyzed 7 Randomized Controlled Trials (RCTs) and found that use of ivermectin reduces risk of death from Covid-19 by 81% as compared to controls.
Each study on its own, and the set of studies combined, found that ivermectin was effective against Covid-19.
“A total of 1323 patients were randomized in 7 RCTs per-formed in 6 countries. Four trials were multicentric. Iver-mectin treatment resulted in a lower mortality when compared to placebo: 14/703 (2%) vs 57/620 (9%),P<0.01, odds ratio 0.19 (0.10, 0.34).”
The p-value for the meta-analysis was less than 0.01, which is clearly statistically significant. And the odds ratio means that Ivermectin reduced mortality by 81%, reducing risk of death from 1.00 for controls to 19% by comparison.
RCTs are the so-called gold standard for studies, and this is a meta-analysis which combines several RCTs. These results are far better than any set of studies on Remdesivir, an approved and widely used (to the tune of 3 billion dollars) medication. And yet ivermectin is still rejected by medical authorities and government, costing untold suffering and a massive death toll, most of which could be avoided by prompt use of ivermectin and use of Vitamin D as a prophylaxis and an adjunct treatment.
Ronald L Conte Jr
“an author, not a doctor”